nanotech-investing CEL-SCI Presentation at LD Micro "Main Event" Available on Tuesday, October 21, 2025
nanotech-investing Dr. Giovanni Selvaggi, Who Has Brought Several Oncology Drugs to Market, Joins CEL-SCI as Clinical Advisor
nanotech-investing CEL-SCI Receives FDA Go-Ahead for Its Confirmatory Study of Multikine in the Treatment of Head & Neck Cancer
Benz Announces that Icon Delivers Shallow High-Grade Discovery as Large-Scale System Continues to Grow
Benz Announces that Icon Delivers Shallow High-Grade Discovery as Large-Scale System Continues to Grow